LEEP or Cone Biopsy for Excision of Cervical Dysplasia? medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Statement on BOT’s Decision Regarding Nikole Hannah-Jones’s Appointment
As members of the faculty of the Department of English and Comparative Literature, we write to express our alarm about the recent denial of tenure of Nikole Hannah-Jones for an endowed Knight professorship at the UNC Hussman School of Journalism and Media. Should the UNC Board of Trustees’ decision stand, it has implications that extend far beyond the facts of this case. We address three of those issues below.
Our first concern is about shared governance and the belief in the integrity and professionalism of the process that allows us to recruit, hire, and retain world-class scholars, researchers, and writers. The denial of tenure of Nikole Hannah-Jones has already drawn world-wide scrutiny about the fairness of that process. So far that scrutiny has played itself out in the press and on social media platforms. Of course, damage to and loss of reputation devastates people but such damage also does incalcu
UNC Disputes That 1619 Project Journalist Nikole Hannah-Jones Was Ever Offered Tenured Position amren.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from amren.com Daily Mail and Mail on Sunday newspapers.
This is viewer supported news. Please do your part today.Donate
Protests and vigils were held across the U.S. to mark one year since the police murder of George Floyd in Minneapolis. Floyd’s death sparked a national uprising and global movement against systemic racism and police brutality. Elizabeth Hinton, an associate professor of history and African American studies at Yale University and a professor of law at Yale Law School, connects the Black Lives Matter protests to a long history of Black rebellion against police violence in her new book “America on Fire” and notes that the U.S. has had previous opportunities to address systemic racism and state violence, but change remains elusive. “Every time inequality and police violence is evaluated, all of these structural solutions are always suggested, and yet they’re never taken up,” Hinton says.
by WRAL TechWire May 26, 2021 .
DURHAM –Inhalon Biopharma is developing a “muco-trapping” antibody platform that could be used to treat acute respiratory infections, including COVID-19, and the Durham-based startup has now been awarded a $7 million contract by the United States Army Medical Research & Development Command (USAMRDC).
The contract will allow the company to conduct a placebo-controlled Phase 1 and Phase 2a study of its technology in COVID-19 outpatients, the company shared in a statement.
The technology, currently designated IN-006, is described by the company as a potent, neutralizing monoclonal antibody that is being investigated as a possible treatment for COVID-19.
The company expects results of the study in 2022.